These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21557768

  • 1. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ, Wiseman E, George J, Katelaris PH, Seow F, Fung C, Ngu MC.
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
    Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1536-43. PubMed ID: 21950746
    [Abstract] [Full Text] [Related]

  • 4. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 5. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J.
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [Abstract] [Full Text] [Related]

  • 6. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function.
    Park GJ, Katelaris PH, Jones DB, Seow F, Le Couteur DG, Ngu MC.
    Hepatology; 2003 Nov; 38(5):1227-36. PubMed ID: 14578861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K.
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L.
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
    Fierbinteanu-Braticevici C, Baicus C, Tribus L, Papacocea R.
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):153-9. PubMed ID: 21725512
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S, Jensen D, Hart J, Mohanty SR.
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [Abstract] [Full Text] [Related]

  • 16. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.
    Tsang SW, Ng WF, Wu BP, Chow DA, Li ET, Wong TC.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822
    [Abstract] [Full Text] [Related]

  • 19. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.